The following clinical trials are currently open at Jefferson.
Learn about participating in clinical trials
| Open Clinical Trials and Research Studies as of October 2009
|
Jefferson Pancreas Tumor Registry A research study that consists of completing patient, family and non-family questionnaires to collect and analyze data about
family history, demographic variables and environmental/occupational risk factors of current pancreatic cancer patients.
|
Fatigue, Physical Functioning, and Quality of Life in Patients with Pancreatic and Periampullary Cancers Following Surgery,
Chemotherapy and/or Radiation Therapy The purpose of this pilot study is to determine the effects of a walking program on fatigue, physical functioning and quality
of life (QOL) in post-operative patients with pancreatic cancer (PC) and periampullary cancers (bile duct, ampulla, duodenum)
who have had surgery alone or are undergoing adjuvant therapy with chemotherapy (CT) and/or radiation therapy (RT).
|
A Randomized Trial of Two Surgical Techniques for Pancreatic Remnant Closure in Patients Undergoing a Distal Pancreatectomy The purpose of this trial is to determine whether a standard closure or closure with fibrin glue and patch will improve the
pancreatic fistula rate after distal pancreatectomy.
|
Collection, Banking and Evaluation of Tissues, Blood, Pancreatic Juice and Bile Samples are collected from patients with pancreatic and related carcinomas while undergoing surgical resection.
|
A Randomized Controlled Trial of Intraoperative Celiac Plexus Neurolysis for Patients with Operable (Resectable and Unresectable)
Pancreatic and Periampullary Cancer (Phase III) A study to determine if the addition of an intraoperative alcohol nerve block in patients undergoing surgical intervention
for pancreatic cancer will result in a decrease in cancer associated pain.
|
A Multinational, Randomized, Double-Blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks Versus Placebo in
Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer Primary Objective: To demonstrate improvement in overall survival (OS) with aflibercept by comparison to placebo in patients
treated with gemcitabine for metastatic pancreatic cancer.
|
Vaccine Study for Surgically Resected Pancreatic Cancer (Phase II) Primary Objective: To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment
with a vaccine given with chemotherapy and chemoradiation.
|